Liposomal formulation for joint lubrication

The present invention provides a pharmaceutical composition for the lubrication of joints, the pharmaceutical composition comprising a non-ionic tonicity agent comprising a polyol, and liposomes comprising at least one membrane comprising at least one phospholipid (PL) selected from a glycerophospho...

Full description

Saved in:
Bibliographic Details
Main Authors YANIV DOLEV, KEREN TURJEMAN, YECHEZKEL BARENHOLZ, MATY AYAL-HERSHKOVITZ, GADI SARFATI
Format Patent
LanguageEnglish
Hebrew
Published 01.09.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides a pharmaceutical composition for the lubrication of joints, the pharmaceutical composition comprising a non-ionic tonicity agent comprising a polyol, and liposomes comprising at least one membrane comprising at least one phospholipid (PL) selected from a glycerophospholipid (GPL), said GPL having two C12-C18 hydrocarbon chains, being the same or different, and sphingomyelin (SM) having a C12-C18 hydrocarbon chain, the pharmaceutical composition being essentially free of an additional pharmaceutically active agent, wherein the at least one membrane has a phase transition temperature in the range of about 20°C to about 39°C and the joint has a joint temperature which is above the phase transition temperature.
Bibliography:Application Number: IL20200272630